Literature DB >> 18809746

P. gingivalis regulates the expression of Cathepsin B and Cystatin C.

R Elkaim1, S Werner, L Kocgozlu, H Tenenbaum.   

Abstract

Porphyromonas gingivalis is a major etiological agent of periodontitis that could affect the expression of Cathepsins B and C by disrupting the balance between these enzymes and their inhibitor, Cystatin C. We tested this hypothesis by infecting human oral epithelial cells with P. gingivalis or activating solely by its lipopolysaccharide. The mRNA level, the enzymatic activity, and the protein expression of Cathepsin B were increased (three-fold) in a dose-dependent manner, while those of Cystatin C decreased (five-fold). No changes were observed for Cathepsin C. Although activation by lipopolysaccharides led to a delayed imbalance (2 days) between Cathepsin B and Cystatin C, this imbalance took place very rapidly during the infection (< 6 hrs), indicating that the whole bacterium contains components that initiate rapid changes in the transcription rates of Cathepsin B and Cystatin C and selectively modify the molecular pathways that lead to this imbalance.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18809746     DOI: 10.1177/154405910808701010

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  6 in total

1.  Implication of Toll/IL-1 receptor domain containing adapters in Porphyromonas gingivalis-induced inflammation.

Authors:  Isaac M Bugueno; Nadia Benkirane-Jessel; Olivier Huck
Journal:  Innate Immun       Date:  2021-05-21       Impact factor: 2.680

2.  Heterogeneous Porphyromonas gingivalis LPS modulates immuno-inflammatory response, antioxidant defense and cytoskeletal dynamics in human gingival fibroblasts.

Authors:  Thanuja D K Herath; Richard P Darveau; Chaminda J Seneviratne; Cun-Yu Wang; Yu Wang; Lijian Jin
Journal:  Sci Rep       Date:  2016-08-19       Impact factor: 4.379

Review 3.  Involvement of Cathepsins in Innate and Adaptive Immune Responses in Periodontitis.

Authors:  Xu Yan; Zhou Wu; Biyao Wang; Tianhao Yu; Yue Hu; Sijian Wang; Chunfu Deng; Baohong Zhao; Hiroshi Nakanishi; Xinwen Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2020-03-31       Impact factor: 2.629

4.  Effect of Lactobacillus reuteri on Gingival Inflammation and Composition of the Oral Microbiota in Patients Undergoing Treatment with Fixed Orthodontic Appliances: Study Protocol of a Randomized Control Trial.

Authors:  Kevimy Agossa; Marie Dubar; Grégoire Lemaire; Alessandra Blaizot; Céline Catteau; Emmanuël Bocquet; Laurent Nawrocki; Emile Boyer; Vincent Meuric; Florence Siepmann
Journal:  Pathogens       Date:  2022-01-18

5.  Porphyromonas gingivalis Differentially Modulates Cell Death Profile in Ox-LDL and TNF-α Pre-Treated Endothelial Cells.

Authors:  Isaac Maximiliano Bugueno; Yacine Khelif; Narendra Seelam; David-Nicolas Morand; Henri Tenenbaum; Jean-Luc Davideau; Olivier Huck
Journal:  PLoS One       Date:  2016-04-28       Impact factor: 3.240

6.  Porphyromonas gingivalis bypasses epithelial barrier and modulates fibroblastic inflammatory response in an in vitro 3D spheroid model.

Authors:  Isaac Maximiliano Bugueno; Fareeha Batool; Laetitia Keller; Sabine Kuchler-Bopp; Nadia Benkirane-Jessel; Olivier Huck
Journal:  Sci Rep       Date:  2018-10-08       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.